SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Davide Roccarina, Matteo Rosselli, Joan Genesca, Emmanuel A. Tsochatzis, Elastography methods for the non-invasive assessment of portal hypertension, Expert Review of Gastroenterology & Hepatology, 2018, 12, 2, 155

    CrossRef

  2. 2
    José I. Fortea, Alexander Zipprich, Carolina Fernandez-Mena, Marta Puerto, Cristina R. Bosoi, Jorge Almagro, Marcus Hollenbach, Juan Bañares, Belén Rodríguez-Sánchez, Emilia Cercenado, Marc-André Clément, Christopher F. Rose, Rafael Bañares, Javier Vaquero, Cristina Ripoll, Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis, Liver International, 2018, 38, 1
  3. 3
    Hongjun Xiang, Yaotian Han, Yuzhong Zhang, Wenqiang Yan, Bing Xu, Fuhao Chu, Tianxin Xie, Menglu Jia, Mengmeng Yan, Rui Zhao, Penglong Wang, Haimin Lei, A New Oleanolic Acid Derivative against CCl4-Induced Hepatic Fibrosis in Rats, International Journal of Molecular Sciences, 2017, 18, 12, 553

    CrossRef

  4. 4
    Càndid Villanueva, Isabel Graupera, Carles Aracil, Edilmar Alvarado, Josep Miñana, Ángela Puente, Virginia Hernandez-Gea, Alba Ardevol, Oana Pavel, Alan Colomo, Mar Concepción, María Poca, Xavier Torras, Josep M. Reñe, Carlos Guarner, A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis, Hepatology, 2017, 65, 5
  5. 5
    Elena Dionigi, Matteo Garcovich, Mauro Borzio, Gioacchino Leandro, Avik Majumdar, Aikaterini Tsami, Vasiliki Arvaniti, Davide Roccarina, Massimo Pinzani, Andrew K Burroughs, James O'Beirne, Emmanuel A Tsochatzis, Bacterial Infections Change Natural History of Cirrhosis Irrespective of Liver Disease Severity, The American Journal of Gastroenterology, 2017, 112, 4, 588

    CrossRef

  6. 6
    Alasdair R. Fraser, Chloe Pass, Paul Burgoyne, Anne Atkinson, Laura Bailey, Audrey Laurie, Neil W.A. McGowan, Akib Hamid, Joanna K. Moore, Benjamin J. Dwyer, Marc L. Turner, Stuart J. Forbes, John D.M. Campbell, Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis, Cytotherapy, 2017, 19, 9, 1113

    CrossRef

  7. 7
    N. Hansi, M. J. Williams, Editorial: the role of statins in the treatment of alcohol-related cirrhosis, Alimentary Pharmacology & Therapeutics, 2017, 46, 9
  8. 8
    Karl Egan, Audrey Dillon, Eimear Dunne, Barry Kevane, Zita Galvin, Patricia Maguire, Dermot Kenny, Stephen Stewart, Fionnuala Ni Ainle, Increased soluble GPVI levels in cirrhosis: evidence for early in vivo platelet activation, Journal of Thrombosis and Thrombolysis, 2017, 43, 1, 54

    CrossRef

  9. 9
    Maria Kalafateli, Konstantinos Mantzoukis, Yan Choi Yau, Ali O. Mohammad, Simran Arora, Susana Rodrigues, Marie Vos, Kassiani Papadimitriou, Douglas Thorburn, James O'Beirne, David Patch, Massimo Pinzani, Marsha Y. Morgan, Banwari Agarwal, Dominic Yu, Andrew K. Burroughs, Emmanuel A. Tsochatzis, Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score, Journal of Cachexia, Sarcopenia and Muscle, 2017, 8, 1
  10. 10
    Apurva S. Shah, Deepak N. Amarapurkar, Natural History of Cirrhosis of Liver after First Decompensation: A Prospective Study in India, Journal of Clinical and Experimental Hepatology, 2017,

    CrossRef

  11. 11
    Simona Onali, Maria Kalafateli, Avik Majumdar, Rachel Westbrook, James O'Beirne, Gioacchino Leandro, David Patch, Emmanuel A. Tsochatzis, Non-selective beta-blockers are not associated with increased mortality in cirrhotic patients with ascites, Liver International, 2017, 37, 9
  12. 12
    Ton Lisman, Robert J. Porte, Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases, Research and Practice in Thrombosis and Haemostasis, 2017, 1, 2
  13. 13
    Anna Baiges, Virginia Hernández-Gea, Jaime Bosch, Pharmacologic prevention of variceal bleeding and rebleeding, Hepatology International, 2017,

    CrossRef

  14. 14
    Yoshio Sakai, Masayuki Takamura, Akihiro Seki, Hajime Sunagozaka, Takeshi Terashima, Takuya Komura, Masatoshi Yamato, Masaki Miyazawa, Kazunori Kawaguchi, Alessandro Nasti, Hatsune Mochida, Soichiro Usui, Nobuhisa Otani, Takahiro Ochiya, Takashi Wada, Masao Honda, Shuichi Kaneko, Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal/stem (regenerative) cell, Regenerative Therapy, 2017, 6, 52

    CrossRef

  15. 15
    Chen-Te Chou, Ran-Chou Chen, Wen-Pei Wu, Ping-Yi Lin, Yao-Li Chen, Prospective Comparison of the Diagnostic Performance of Magnetic Resonance Elastography with Acoustic Radiation Force Impulse Elastography for Pre-operative Staging of Hepatic Fibrosis in Patients with Hepatocellular Carcinoma, Ultrasound in Medicine & Biology, 2017, 43, 12, 2783

    CrossRef

  16. 16
    Emmanuel A. Tsochatzis, Jaime Bosch, Statins in cirrhosis—Ready for prime time, Hepatology, 2017, 66, 3
  17. 17
    J.D. Vorobioff, R.J. Groszmann, Liver Pathophysiology, 2017,

    CrossRef

  18. 18
    Bisheng Zhou, Sheng Zeng, Luyuang Li, Zhiwen Fan, Wenfang Tian, Min Li, Huihui Xu, Xiaoyan Wu, Mingming Fang, Yong Xu, Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2016, 1862, 6, 1203

    CrossRef

  19. 19
    Càndid Villanueva, Agustín Albillos, Joan Genescà, Juan G. Abraldes, Jose L. Calleja, Carles Aracil, Rafael Bañares, Rosa Morillas, María Poca, Beatriz Peñas, Salvador Augustin, Joan Carles Garcia-Pagan, Oana Pavel, Jaume Bosch, Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension, Hepatology, 2016, 63, 1
  20. 20
    Gaetano Bertino, Graziella Privitera, Francesco Purrello, Shirin Demma, Emanuele Crisafulli, Luisa Spadaro, Nikolaos Koukias, Emmanuel A. Tsochatzis, Emerging hepatic syndromes: pathophysiology, diagnosis and treatment, Internal and Emergency Medicine, 2016, 11, 7, 905

    CrossRef

  21. 21
    Won Chang, Jeong Min Lee, Jeong Hee Yoon, Joon Koo Han, Byung Ihn Choi, Jung Hwan Yoon, Kyoung Bun Lee, Kwang-Woong Lee, Nam-Joon Yi, Kyung-Suk Suh, Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes, Radiology, 2016, 280, 1, 88

    CrossRef

  22. 22
    Michael T. Perry, Neal Savjani, Edward I. Bluth, Adriana Dornelles, George Therapondos, Point Shear Wave Elastography in Assessment of Hepatic Fibrosis, Ultrasound Quarterly, 2016, 32, 3, 201

    CrossRef

  23. 23
    Rosa Lombardi, Helen Sambatakou, Ilias Mariolis, Demosthenis Cokkinos, George V. Papatheodoridis, Emmanuel A. Tsochatzis, Prevalence and predictors of liver steatosis and fibrosis in unselected patients with HIV mono-infection, Digestive and Liver Disease, 2016, 48, 12, 1471

    CrossRef

  24. 24
    Seth N. Sclair, Olveen Carrasquillo, Frank Czul, Juan P. Trivella, Hua Li, Lennox Jeffers, Paul Martin, Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems, Digestive Diseases and Sciences, 2016, 61, 10, 2857

    CrossRef

  25. 25
    Lina Sun, Zhiwen Fan, Junliang Chen, Wenfang Tian, Min Li, Huihui Xu, Xiaoyan Wu, Jing Shao, Yaoyao Bian, Mingming Fang, Yong Xu, Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis, Scientific Reports, 2016, 6, 1

    CrossRef

  26. 26
    Basile Njei, Thomas R. McCarty, Jeffrey Luk, Oforbuike Ewelukwa, Ivo Ditah, Joseph K. Lim, Use of transient elastography in patients with HIV–HCV coinfection: A systematic review and meta-analysis, Journal of Gastroenterology and Hepatology, 2016, 31, 10
  27. 27
    Emmanuel A. Tsochatzis, Laurent Castera, Assessing liver disease in HIV–HCV coinfected patients, Current Opinion in HIV and AIDS, 2015, 10, 5, 316

    CrossRef

  28. 28
    Shao-Jung Hsu, Fa-Yauh Lee, Sun-Sang Wang, I-Fang Hsin, Te-Yueh Lin, Hui-Chun Huang, Ching-Chih Chang, Chiao-Lin Chuang, Hsin-Ling Ho, Han-Chieh Lin, Shou-Dong Lee, Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats, Hepatology, 2015, 61, 5
  29. 29
    Amarapurkar Deepak, V dharod Mrudul, Chandnani Madhuri, Baijal Rajiv, kumar Praveen, Jain Mayank, Patel Nikhil, Kamani Praful, Shah Nimish, Kulkarni Sandeep, Gautam Sonali, Shah Apurva, Doshi Soham, Care of patients with liver cirrhosis: How are we doing?, Journal of Public Health and Epidemiology, 2015, 7, 2, 51

    CrossRef

  30. 30
    Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs, Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation, Health Technology Assessment, 2015, 19, 9, 1

    CrossRef

  31. 31
    Seán J. Costelloe, Eleni Theocharidou, Emmanuel Tsochatzis, Evangelos Thalassinos, Nicholas Martin, Guiseppe Fede, Michael Thomas, Anthony K. Burroughs, Hepascore and hyaluronic acid as markers of fibrosis in liver disease of mixed aetiology, European Journal of Gastroenterology & Hepatology, 2015, 27, 3, 313

    CrossRef

  32. 32
    Greg C.G. Hugenholtz, Patrick G. Northup, Robert J. Porte, Ton Lisman, Is there a rationale for treatment of chronic liver disease with antithrombotic therapy?, Blood Reviews, 2015, 29, 2, 127

    CrossRef

  33. 33
    Wenfang Tian, Chenzhi Hao, Zhiwen Fan, Xinyu Weng, Hao Qin, Xiaoyan Wu, Mingming Fang, Qi Chen, Aiguo Shen, Yong Xu, Myocardin related transcription factor A programs epigenetic activation of hepatic stellate cells, Journal of Hepatology, 2015, 62, 1, 165

    CrossRef

  34. 34
    Michael Hagan, Sumeet K Asrani, Jayant Talwalkar, Non-invasive assessment of liver fibrosis and prognosis, Expert Review of Gastroenterology & Hepatology, 2015, 9, 10, 1251

    CrossRef

  35. 35
    Rosa Lombardi, Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease, World Journal of Gastroenterology, 2015, 21, 39, 11044

    CrossRef

  36. You have free access to this content36
    Julio D. Vorobioff, Roberto J. Groszmann, Prevention of portal hypertension: From variceal development to clinical decompensation, Hepatology, 2015, 61, 1
  37. 37
    Tilman Sauerbruch, Martin Mengel, Matthias Dollinger, Alexander Zipprich, Martin Rössle, Elisabeth Panther, Reiner Wiest, Karel Caca, Albrecht Hoffmeister, Holger Lutz, Rüdiger Schoo, Henning Lorenzen, Jonel Trebicka, Beate Appenrodt, Michael Schepke, Rolf Fimmers, Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy, Gastroenterology, 2015, 149, 3, 660

    CrossRef

  38. 38
    Dimitrios S. Karagiannakis, George Papatheodoridis, Jiannis Vlachogiannakos, Recent Advances in Cirrhotic Cardiomyopathy, Digestive Diseases and Sciences, 2015, 60, 5, 1141

    CrossRef

  39. 39
    Hussein M Atta, Reversibility and heritability of liver fibrosis: Implications for research and therapy, World Journal of Gastroenterology, 2015, 21, 17, 5138

    CrossRef

  40. 40
    Ji Woong Roh, Eun Hyea Park, Joon Cheol Song, Young Seung Oh, Tong Yoon Kim, Hyo Suk Kim, Sungmin Lim, ST-Segment Elevation Myocardial Infarction as a Result of Coronary Artery Ectasia-Related Intracoronary Thrombus in a Patient with Liver Cirrhosis, The Korean Journal of Critical Care Medicine, 2015, 30, 4, 358

    CrossRef

  41. 41
    Andrew J. Muir, Understanding the Complexities of Cirrhosis, Clinical Therapeutics, 2015, 37, 8, 1822

    CrossRef

  42. 42
    Fredrik Åberg, Jaana Helenius-Hietala, Jukka Meurman, Helena Isoniemi, Association between dental infections and the clinical course of chronic liver disease, Hepatology Research, 2014, 44, 3
  43. 43
    Alberto Ferrarese, Emmanuel Tsochatzis, Andrew Kenneth Burroughs, Marco Senzolo, Beta-blockers in cirrhosis: Therapeutic window or an aspirin for all?, Journal of Hepatology, 2014, 61, 2, 449

    CrossRef

  44. You have free access to this content44
    Hiroki Nishikawa, Yukio Osaki, Clinical significance of therapy using branched-chain amino acid granules in patients with liver cirrhosis and hepatocellular carcinoma, Hepatology Research, 2014, 44, 2
  45. 45
    Emmanuel Tsochatzis, Sara Bruno, Graziella Isgro, Andrew Hall, Eleni Theocharidou, Pinelopi Manousou, Amar P. Dhillon, Andrew K. Burroughs, Tu Vinh Luong, Collagen proportionate area is superior to other histological methods for sub-classifying cirrhosis and determining prognosis, Journal of Hepatology, 2014, 60, 5, 948

    CrossRef

  46. 46
    Emmanuel A Tsochatzis, Jaime Bosch, Andrew K Burroughs, Future treatments of cirrhosis, Expert Review of Gastroenterology & Hepatology, 2014, 8, 5, 571

    CrossRef

  47. 47
    Edoardo G. Giannini, Franco Trevisani, Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care, Hepatology, 2014, 60, 4
  48. 48
    Emmanuel A Tsochatzis, Jaime Bosch, Andrew K Burroughs, Liver cirrhosis, The Lancet, 2014, 383, 9930, 1749

    CrossRef

  49. 49
    Hussein Atta, Mahmoud El-Rehany, Olfat Hammam, Hend Abdel-Ghany, Maggie Ramzy, Martin Roderfeld, Elke Roeb, Ayman Al-Hendy, Salama Abdel Raheim, Hatem Allam, Heba Marey, Matias A. Avila, Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl4-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression, PLoS ONE, 2014, 9, 11, e112384

    CrossRef

  50. 50
    Annalisa Berzigotti, Jaime Bosch, Pharmacologic Management of Portal Hypertension, Clinics in Liver Disease, 2014, 18, 2, 303

    CrossRef

  51. 51
    Jeong Hee Yoon, Jeong Min Lee, Joon Koo Han, Byung Ihn Cho, Shear Wave Elastography for Liver Stiffness Measurement in Clinical Sonographic Examinations, Journal of Ultrasound in Medicine, 2014, 33, 3
  52. 52
    Kanta Jobara, Toshimi Kaido, Tomohide Hori, Keiko Iwaisako, Kosuke Endo, Yoichiro Uchida, Shinji Uemoto, Whey-hydrolyzed peptide-enriched immunomodulating diet prevents progression of liver cirrhosis in rats, Nutrition, 2014, 30, 10, 1195

    CrossRef

  53. 53
    Christos Triantos, Konstantinos Thomopoulos, Chrysoula Lampropoulou-Karatza, β Blockers in Liver Cirrhosis, Gastroenterology, 2014, 147, 4, 941

    CrossRef

  54. 54
    Matteo Rosselli, Jane MacNaughtan, Rajiv Jalan, Massimo Pinzani, Beyond scoring: a modern interpretation of disease progression in chronic liver disease, Gut, 2013, 62, 9, 1234

    CrossRef

  55. 55
    Jaime Bosch, Carvedilol: the β-blocker of choice for portal hypertension?, Gut, 2013, 62, 11, 1529

    CrossRef

  56. 56
    Armando Tripodi, Massimo Primignani, Laura Lemma, Veena Chantarangkul, Pier Mannuccio Mannucci, Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis, Journal of Hepatology, 2013, 59, 2, 265

    CrossRef

  57. 57
    Siddharth Singh, Larissa L. Fujii, Mohammad Hassan Murad, Zhen Wang, Sumeet K. Asrani, Richard L. Ehman, Patrick S. Kamath, Jayant A. Talwalkar, Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis, Clinical Gastroenterology and Hepatology, 2013, 11, 12, 1573

    CrossRef

  58. 58
    Julia O'Brien, Christos Triantos, Andrew K. Burroughs, Management of varices in patients with cirrhosis, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 7, 402

    CrossRef

  59. 59
    Jeong Hee Yoon, Jeong Min Lee, Hyun Sik Woo, Mi Hye Yu, Ijin Joo, Eun Sun Lee, Ji Young Sohn, Kyung Boon Lee, Joon Koo Han, Byung Ihn Choi, Staging of Hepatic Fibrosis: Comparison of Magnetic Resonance Elastography and Shear Wave Elastography in the Same Individuals, Korean Journal of Radiology, 2013, 14, 2, 202

    CrossRef

  60. 60
    Bjørn S. Madsen, Troels Havelund, Aleksander Krag, Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers, Advances in Therapy, 2013, 30, 7, 659

    CrossRef

  61. 61
    Sumeet K. Asrani, Patrick S. Kamath, Evaluating prognosis,
  62. 62
    Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster, Probiotics for people with hepatic encephalopathy, The Cochrane Library,